Ogawan, Victoria S.

HRN: 18-43-08  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2023
CO-AMOXICLAV 625MG (TAB)
08/02/2023
08/10/2023
PO
625mg
BID
7 Days
Waiting Final Action 
08/02/2023
CEFTRIAXONE 1G (VIAL)
08/02/2023
08/08/2023
IV
2gms
OD
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: